204 related articles for article (PubMed ID: 24204564)
1. Methylated DNA binding domain protein 2 (MBD2) coordinately silences gene expression through activation of the microRNA hsa-mir-496 promoter in breast cancer cell line.
Alvarado S; Wyglinski J; Suderman M; Andrews SA; Szyf M
PLoS One; 2013; 8(10):e74009. PubMed ID: 24204564
[TBL] [Abstract][Full Text] [Related]
2. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
3. Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells.
Mian OY; Wang SZ; Zhu SZ; Gnanapragasam MN; Graham L; Bear HD; Ginder GD
Mol Cancer Res; 2011 Aug; 9(8):1152-62. PubMed ID: 21693597
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide binding of MBD2 reveals strong preference for highly methylated loci.
Menafra R; Brinkman AB; Matarese F; Franci G; Bartels SJ; Nguyen L; Shimbo T; Wade PA; Hubner NC; Stunnenberg HG
PLoS One; 2014; 9(6):e99603. PubMed ID: 24927503
[TBL] [Abstract][Full Text] [Related]
5. Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer.
Wee EJ; Peters K; Nair SS; Hulf T; Stein S; Wagner S; Bailey P; Lee SY; Qu WJ; Brewster B; French JD; Dobrovic A; Francis GD; Clark SJ; Brown MA
Oncogene; 2012 Sep; 31(38):4182-95. PubMed ID: 22231446
[TBL] [Abstract][Full Text] [Related]
6. MBD2 upregulates miR-301a-5p to induce kidney cell apoptosis during vancomycin-induced AKI.
Wang J; Li H; Qiu S; Dong Z; Xiang X; Zhang D
Cell Death Dis; 2017 Oct; 8(10):e3120. PubMed ID: 29022913
[TBL] [Abstract][Full Text] [Related]
7. Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma.
Chen YJ; Luo J; Yang GY; Yang K; Wen SQ; Zou SQ
World J Gastroenterol; 2012 Aug; 18(29):3849-61. PubMed ID: 22876037
[TBL] [Abstract][Full Text] [Related]
8. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
[TBL] [Abstract][Full Text] [Related]
9. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
Lin X; Nelson WG
Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasiveness.
Cheishvili D; Chik F; Li CC; Bhattacharya B; Suderman M; Arakelian A; Hallett M; Rabbani SA; Szyf M
Carcinogenesis; 2014 Nov; 35(11):2436-46. PubMed ID: 25178277
[TBL] [Abstract][Full Text] [Related]
11. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells.
Devailly G; Grandin M; Perriaud L; Mathot P; Delcros JG; Bidet Y; Morel AP; Bignon JY; Puisieux A; Mehlen P; Dante R
Nucleic Acids Res; 2015 Jul; 43(12):5838-54. PubMed ID: 26007656
[TBL] [Abstract][Full Text] [Related]
13. miR-373 negatively regulates methyl-CpG-binding domain protein 2 (MBD2) in hilar cholangiocarcinoma.
Chen Y; Luo J; Tian R; Sun H; Zou S
Dig Dis Sci; 2011 Jun; 56(6):1693-701. PubMed ID: 21086164
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells.
Wang G; Wei LN; Loh HH
J Biol Chem; 2003 Oct; 278(42):40550-6. PubMed ID: 12890683
[TBL] [Abstract][Full Text] [Related]
15. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2.
Stefanska B; Suderman M; Machnes Z; Bhattacharyya B; Hallett M; Szyf M
Carcinogenesis; 2013 Dec; 34(12):2738-49. PubMed ID: 23955541
[TBL] [Abstract][Full Text] [Related]
16. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
Gu P; Le Menuet D; Chung AC; Cooney AJ
Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
[TBL] [Abstract][Full Text] [Related]
17. TACC3 mediates the association of MBD2 with histone acetyltransferases and relieves transcriptional repression of methylated promoters.
Angrisano T; Lembo F; Pero R; Natale F; Fusco A; Avvedimento VE; Bruni CB; Chiariotti L
Nucleic Acids Res; 2006; 34(1):364-72. PubMed ID: 16410616
[TBL] [Abstract][Full Text] [Related]
18. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
19. Promoter-specific activation and demethylation by MBD2/demethylase.
Detich N; Theberge J; Szyf M
J Biol Chem; 2002 Sep; 277(39):35791-4. PubMed ID: 12177048
[TBL] [Abstract][Full Text] [Related]
20. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
Moazzeni H; Najafi A; Khani M
Mol Cell Probes; 2017 Aug; 34():45-52. PubMed ID: 28546132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]